Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Response of influenza vaccines against heterovariant influenza virus strains in adults with chronic diseases.

Journal of clinical immunology - 1 Sept 2007

Baldo V, Baldovin T, Floreani A, Fragapane E, Trivello R

Abstract excerpt

The ability of influenza vaccination to provide cross-protection against heterovariant influenza strains was evaluated in a double-blind, randomized, trial in north-east Italy during the winter of 2005-2006. Of 238 adult subjects with underlying chronic diseases, 120 received MF59-adjuvanted subu...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Chronic Disease
Share to Double-Blind Method

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Influenza A virus

Share to Influenza B virus

Share to Influenza, Human

Share to Influenza Vaccines

Share to Vaccines, Subunit

Source

Identifiers

PMID: 17514499
DOI: 10.1007/s10875-007-9100-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17514499-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Response of influenza vaccines against heterovariant influenza virus strains in adults with chronic diseases.PMID 17514499Read ↗

Immunogenicity of Three Different Influenza Vaccines against Homologous and Heterologous Strains in Nursing Home Elderly ResidentsSemantic proximity Read ↗

A Heterologous MF59-Adjuvanted H5N1 Prepandemic Influenza Booster Vaccine Induces a Robust, Cross-Reactive Immune Response in Adults and the ElderlySemantic proximity Read ↗

Vaccination focusing immunity on conserved antigens protects mice and ferrets against virulent H1N1 and H5N1 influenza A virusesSemantic proximity Read ↗

IL-15 adjuvanted multivalent vaccinia-based universal influenza vaccine requires CD4 <sup>+</sup> T cells for heterosubtypic protectionSemantic proximity Read ↗

MVA-Based H5N1 Vaccine Affords Cross-Clade Protection in Mice against Influenza A/H5N1 Viruses at Low Doses and after Single ImmunizationSemantic proximity Read ↗

Vaccine effectiveness against influenza A(H3N2) and B among laboratory‐confirmed, hospitalised older adults, Europe, 2017‐18: A season of B lineage mismatched to the trivalent vaccineSemantic proximity Read ↗

Multi-Epitope Peptide-Based and Vaccinia-Based Universal Influenza Vaccine Candidates Subjected to Clinical TrialsSemantic proximity Read ↗

Influenza B: Prospects for the Development of Cross-Protective VaccinesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.